NovoCure Ltd logo

NovoCure Ltd

1645113

Novocure is a global oncology company striving to extend survival in some of the most aggressive forms of cancer. They develop and commercialize innovative therapies, including Tumor Treating Fields (TTFields). The company is known for its patient-forward approach and significant research in cancer treatment.

86
Altamente Confiable
Puntuación de Confianza

Registro Oficial

Nombre Legal
NovoCure Ltd
Número de organización
1645113
Número de IVA
000000000
Estado de la Empresa
Active
Dirección
NO. 4 THE FORUM, ST. HELIER,
Códigos de Industria
Surgical & Medical Instruments & Apparatus, 3841

Análisis de Calidad IA

Industria
Biotechnology
SSL/HTTPS
Seguro
Correo profesional
Correo de contacto
usinvestorinfo@novocure.com

🌟 Empresas similares de confianza

Metagenomi, Inc.

Metagenomi, Inc. logo
74/100 · Confiable

Metagenomi is an in vivo genome editing company creating curative genetic medicines using proprietary technologies. They leverage metagenomics to discover editing tools potentially capable of correcting any type of genetic mutation. The company focuses on diseases with well-understood biology and clear regulatory pathways, and intends to expand their pipeline through genetic editing capabilities.

5959 HORTON STREET, Estados Unidos
Ver perfil

ARCTICZYMES TECHNOLOGIES ASA

ARCTICZYMES TECHNOLOGIES ASA logo
80/100 · Altamente Confiable

ArcticZymes Technologies es una empresa de biotecnología especializada en el desarrollo y la producción de enzimas. Ofrece nucleasas para la biofabricación y el diagnóstico molecular, incluyendo las Nucleasas Activas en Sal (SAN). La empresa es conocida por sus polimerasas y enzimas utilizadas en aplicaciones de investigación e industriales.

Sykehusvegen 23, Noruega
Ver perfil

ACD PHARMACEUTICALS AS

ACD PHARMACEUTICALS AS logo
80/100 · Altamente Confiable

ACD Pharma is a Norwegian R&D company developing biocontrol products based on bacteriophages, focusing on combating harmful bacteria in animals and humans. They launched Custus®YRS, the world's first bacteriophage product for aquaculture. They collaborate with pharmaceutical and scientific teams to fight antibiotic resistance, extending their advancements across sectors.

Lofoten Bio Centre, Noruega10 empleados
Ver perfil